Reviews Risperidone


No reviews yet.

Risperdal Drug Description
RISPERDAL®
(risperidone) Tablets
(risperidone) Oral Solution
RISPERDAL® M-TAB®
(risperidone) Orally Disintegrating Tablets


WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. RISPERDAL® (risperidone) is not approved for the treatment of patients with dementia-related psychosis. [See Warnings and PRECAUTIONS]

DRUG DESCRIPTION



What are the possible side effects of risperidone (Risperdal, Risperdal M-Tab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using risperidone and call your doctor at once if you have any of these serious side effects:

fever, stiff muscles, confusion, sweating, fast or uneven heartbeats;
restless muscle movements in your eyes, tongue, jaw, or neck;
tremor (uncontrolled shaking);
trouble swallowing;...
Read All Potential Side Effects for Risperdal »




RISPERDAL® contains risperidone, a psychotropic agent belonging to the
chemical class of benzisoxazole derivatives. The chemical designation is 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one.
Its molecular formula is C23H27FN4O2
and its molecular weight is 410.49. The structural formula is:







Risperidone is a white to slightly beige powder. It is practically insoluble in water, freely soluble in methylene chloride, and soluble in methanol and 0.1 N HCl.
RISPERDAL® Tablets are available in 0.25 mg (dark yellow), 0.5 mg (red-brown), 1 mg (white), 2 mg (orange), 3 mg (yellow), and 4 mg (green) strengths. RISPERDAL® tablets contain the following inactive ingredients: colloidal silicon dioxide, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium lauryl sulfate, and starch (corn). The 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg tablets also contain talc and titanium dioxide. The 0.25 mg tablets contain yellow iron oxide; the 0.5 mg tablets contain red iron oxide; the 2 mg tablets contain FD&C Yellow No. 6 Aluminum Lake; the 3 mg and 4 mg tablets contain D&C Yellow No. 10; the 4 mg tablets contain FD&C Blue No. 2 Aluminum Lake.
RISPERDAL® is also available as a 1 mg/mL oral solution. RISPERDAL® Oral Solution contains the following inactive ingredients: tartaric acid, benzoic acid, sodium hydroxide, and purified water.
RISPERDAL® M-TAB® Orally Disintegrating Tablets are available in 0.5
mg (light coral), 1 mg (light coral), 2 mg (light coral), 3 mg (coral), and
4 mg (coral) strengths. RISPERDAL® M-TAB® Orally Disintegrating Tablets
contain the following inactive ingredients: Amberlite® resin, gelatin, mannitol, glycine, simethicone, carbomer, sodium hydroxide, aspartame, red ferric oxide,
and peppermint oil. In addition, the 3 mg and 4 mg RISPERDAL® M-TAB®
Orally Disintegrating Tablets contain xanthan gum.
Last reviewed on RxList: 9/3/2008




Risperdal Drug Description
RISPERDAL®
(risperidone) Tablets
(risperidone) Oral Solution
RISPERDAL® M-TAB®
(risperidone) Orally Disintegrating Tablets


WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. RISPERDAL® (risperidone) is not approved for the treatment of patients with dementia-related psychosis. [See Warnings and PRECAUTIONS]

DRUG DESCRIPTION



What are the possible side effects of risperidone (Risperdal, Risperdal M-Tab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using risperidone and call your doctor at once if you have any of these serious side effects:

fever, stiff muscles, confusion, sweating, fast or uneven heartbeats;
restless muscle movements in your eyes, tongue, jaw, or neck;
tremor (uncontrolled shaking);
trouble swallowing;...
Read All Potential Side Effects for Risperdal »




RISPERDAL® contains risperidone, a psychotropic agent belonging to the
chemical class of benzisoxazole derivatives. The chemical designation is 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one.
Its molecular formula is C23H27FN4O2
and its molecular weight is 410.49. The structural formula is:







Risperidone is a white to slightly beige powder. It is practically insoluble in water, freely soluble in methylene chloride, and soluble in methanol and 0.1 N HCl.
RISPERDAL® Tablets are available in 0.25 mg (dark yellow), 0.5 mg (red-brown), 1 mg (white), 2 mg (orange), 3 mg (yellow), and 4 mg (green) strengths. RISPERDAL® tablets contain the following inactive ingredients: colloidal silicon dioxide, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium lauryl sulfate, and starch (corn). The 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg tablets also contain talc and titanium dioxide. The 0.25 mg tablets contain yellow iron oxide; the 0.5 mg tablets contain red iron oxide; the 2 mg tablets contain FD&C Yellow No. 6 Aluminum Lake; the 3 mg and 4 mg tablets contain D&C Yellow No. 10; the 4 mg tablets contain FD&C Blue No. 2 Aluminum Lake.
RISPERDAL® is also available as a 1 mg/mL oral solution. RISPERDAL® Oral Solution contains the following inactive ingredients: tartaric acid, benzoic acid, sodium hydroxide, and purified water.
RISPERDAL® M-TAB® Orally Disintegrating Tablets are available in 0.5
mg (light coral), 1 mg (light coral), 2 mg (light coral), 3 mg (coral), and
4 mg (coral) strengths. RISPERDAL® M-TAB® Orally Disintegrating Tablets
contain the following inactive ingredients: Amberlite® resin, gelatin, mannitol, glycine, simethicone, carbomer, sodium hydroxide, aspartame, red ferric oxide,
and peppermint oil. In addition, the 3 mg and 4 mg RISPERDAL® M-TAB®
Orally Disintegrating Tablets contain xanthan gum.
Last reviewed on RxList: 9/3/2008




Risperdal Drug Description
RISPERDAL®
(risperidone) Tablets
(risperidone) Oral Solution
RISPERDAL® M-TAB®
(risperidone) Orally Disintegrating Tablets


WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. RISPERDAL® (risperidone) is not approved for the treatment of patients with dementia-related psychosis. [See Warnings and PRECAUTIONS]

DRUG DESCRIPTION



What are the possible side effects of risperidone (Risperdal, Risperdal M-Tab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using risperidone and call your doctor at once if you have any of these serious side effects:

fever, stiff muscles, confusion, sweating, fast or uneven heartbeats;
restless muscle movements in your eyes, tongue, jaw, or neck;
tremor (uncontrolled shaking);
trouble swallowing;...
Read All Potential Side Effects for Risperdal »




RISPERDAL® contains risperidone, a psychotropic agent belonging to the
chemical class of benzisoxazole derivatives. The chemical designation is 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one.
Its molecular formula is C23H27FN4O2
and its molecular weight is 410.49. The structural formula is:







Risperidone is a white to slightly beige powder. It is practically insoluble in water, freely soluble in methylene chloride, and soluble in methanol and 0.1 N HCl.
RISPERDAL® Tablets are available in 0.25 mg (dark yellow), 0.5 mg (red-brown), 1 mg (white), 2 mg (orange), 3 mg (yellow), and 4 mg (green) strengths. RISPERDAL® tablets contain the following inactive ingredients: colloidal silicon dioxide, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium lauryl sulfate, and starch (corn). The 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg tablets also contain talc and titanium dioxide. The 0.25 mg tablets contain yellow iron oxide; the 0.5 mg tablets contain red iron oxide; the 2 mg tablets contain FD&C Yellow No. 6 Aluminum Lake; the 3 mg and 4 mg tablets contain D&C Yellow No. 10; the 4 mg tablets contain FD&C Blue No. 2 Aluminum Lake.
RISPERDAL® is also available as a 1 mg/mL oral solution. RISPERDAL® Oral Solution contains the following inactive ingredients: tartaric acid, benzoic acid, sodium hydroxide, and purified water.
RISPERDAL® M-TAB® Orally Disintegrating Tablets are available in 0.5
mg (light coral), 1 mg (light coral), 2 mg (light coral), 3 mg (coral), and
4 mg (coral) strengths. RISPERDAL® M-TAB® Orally Disintegrating Tablets
contain the following inactive ingredients: Amberlite® resin, gelatin, mannitol, glycine, simethicone, carbomer, sodium hydroxide, aspartame, red ferric oxide,
and peppermint oil. In addition, the 3 mg and 4 mg RISPERDAL® M-TAB®
Orally Disintegrating Tablets contain xanthan gum.
Last reviewed on RxList: 9/3/2008




Risperdal Drug Description
RISPERDAL®
(risperidone) Tablets
(risperidone) Oral Solution
RISPERDAL® M-TAB®
(risperidone) Orally Disintegrating Tablets


WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. RISPERDAL® (risperidone) is not approved for the treatment of patients with dementia-related psychosis. [See Warnings and PRECAUTIONS]

DRUG DESCRIPTION



What are the possible side effects of risperidone (Risperdal, Risperdal M-Tab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using risperidone and call your doctor at once if you have any of these serious side effects:

fever, stiff muscles, confusion, sweating, fast or uneven heartbeats;
restless muscle movements in your eyes, tongue, jaw, or neck;
tremor (uncontrolled shaking);
trouble swallowing;...
Read All Potential Side Effects for Risperdal »




RISPERDAL® contains risperidone, a psychotropic agent belonging to the
chemical class of benzisoxazole derivatives. The chemical designation is 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one.
Its molecular formula is C23H27FN4O2
and its molecular weight is 410.49. The structural formula is:







Risperidone is a white to slightly beige powder. It is practically insoluble in water, freely soluble in methylene chloride, and soluble in methanol and 0.1 N HCl.
RISPERDAL® Tablets are available in 0.25 mg (dark yellow), 0.5 mg (red-brown), 1 mg (white), 2 mg (orange), 3 mg (yellow), and 4 mg (green) strengths. RISPERDAL® tablets contain the following inactive ingredients: colloidal silicon dioxide, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium lauryl sulfate, and starch (corn). The 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg tablets also contain talc and titanium dioxide. The 0.25 mg tablets contain yellow iron oxide; the 0.5 mg tablets contain red iron oxide; the 2 mg tablets contain FD&C Yellow No. 6 Aluminum Lake; the 3 mg and 4 mg tablets contain D&C Yellow No. 10; the 4 mg tablets contain FD&C Blue No. 2 Aluminum Lake.
RISPERDAL® is also available as a 1 mg/mL oral solution. RISPERDAL® Oral Solution contains the following inactive ingredients: tartaric acid, benzoic acid, sodium hydroxide, and purified water.
RISPERDAL® M-TAB® Orally Disintegrating Tablets are available in 0.5
mg (light coral), 1 mg (light coral), 2 mg (light coral), 3 mg (coral), and
4 mg (coral) strengths. RISPERDAL® M-TAB® Orally Disintegrating Tablets
contain the following inactive ingredients: Amberlite® resin, gelatin, mannitol, glycine, simethicone, carbomer, sodium hydroxide, aspartame, red ferric oxide,
and peppermint oil. In addition, the 3 mg and 4 mg RISPERDAL® M-TAB®
Orally Disintegrating Tablets contain xanthan gum.
Last reviewed on RxList: 9/3/2008




Risperdal Drug Description
RISPERDAL®
(risperidone) Tablets
(risperidone) Oral Solution
RISPERDAL® M-TAB®
(risperidone) Orally Disintegrating Tablets


WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. RISPERDAL® (risperidone) is not approved for the treatment of patients with dementia-related psychosis. [See Warnings and PRECAUTIONS]

DRUG DESCRIPTION



What are the possible side effects of risperidone (Risperdal, Risperdal M-Tab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using risperidone and call your doctor at once if you have any of these serious side effects:

fever, stiff muscles, confusion, sweating, fast or uneven heartbeats;
restless muscle movements in your eyes, tongue, jaw, or neck;
tremor (uncontrolled shaking);
trouble swallowing;...
Read All Potential Side Effects for Risperdal »




RISPERDAL® contains risperidone, a psychotropic agent belonging to the
chemical class of benzisoxazole derivatives. The chemical designation is 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one.
Its molecular formula is C23H27FN4O2
and its molecular weight is 410.49. The structural formula is:







Risperidone is a white to slightly beige powder. It is practically insoluble in water, freely soluble in methylene chloride, and soluble in methanol and 0.1 N HCl.
RISPERDAL® Tablets are available in 0.25 mg (dark yellow), 0.5 mg (red-brown), 1 mg (white), 2 mg (orange), 3 mg (yellow), and 4 mg (green) strengths. RISPERDAL® tablets contain the following inactive ingredients: colloidal silicon dioxide, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium lauryl sulfate, and starch (corn). The 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg tablets also contain talc and titanium dioxide. The 0.25 mg tablets contain yellow iron oxide; the 0.5 mg tablets contain red iron oxide; the 2 mg tablets contain FD&C Yellow No. 6 Aluminum Lake; the 3 mg and 4 mg tablets contain D&C Yellow No. 10; the 4 mg tablets contain FD&C Blue No. 2 Aluminum Lake.
RISPERDAL® is also available as a 1 mg/mL oral solution. RISPERDAL® Oral Solution contains the following inactive ingredients: tartaric acid, benzoic acid, sodium hydroxide, and purified water.
RISPERDAL® M-TAB® Orally Disintegrating Tablets are available in 0.5
mg (light coral), 1 mg (light coral), 2 mg (light coral), 3 mg (coral), and
4 mg (coral) strengths. RISPERDAL® M-TAB® Orally Disintegrating Tablets
contain the following inactive ingredients: Amberlite® resin, gelatin, mannitol, glycine, simethicone, carbomer, sodium hydroxide, aspartame, red ferric oxide,
and peppermint oil. In addition, the 3 mg and 4 mg RISPERDAL® M-TAB®
Orally Disintegrating Tablets contain xanthan gum.
Last reviewed on RxList: 9/3/2008





Other reviews about Risperidone on wordpress

Risperidone and Testosterone
  by texasgomer
I have been taking Risperidone for more than 10 years. It was the first anti-psychotic I could stand to take as a maintenance drug. I am grateful […]


Cochrane - Risperidone versus placebo for schizophrenia (Protocol)
  by sjennings29
    Risperidone versus placebo for schizophrenia (Protocol), Rattehalli RD, Jayaram MB. (Protocol) Cochrane Database of Systematic Reviews 2008,Issue 1. Art. No.: CD006918. DOI: 10.1002/14651858.CD006918. Abstract: Conventional antipsychotic drugs, introduced […]


Kitty needs some risperidone.
  by Kate
If you're curious, read more about the anti-psychotic risperidone HERE. It's an *atypical* anti-psychotic, one of a newer generation of drugs that has fewer Parkinson's Syndrome-like side effects. These […]


Antipsychotics: History - Then and Now
  by Your Friend
The Times-News Modern mind medicines begin to lose luster January 27, 2009 Hundreds of years ago, people with mental illness might be burned at the stake or locked away in […]


Drug Maker Told Studies Would Aid It, Papers Say
  by Boulderdash
By Gardiner Harris An influential Harvard child psychiatrist told the drug giant Johnson & Johnson that planned studies of its medicines in children would yield results benefiting the company, […]


5|25: Celebrating Five Years of Autism Science Day 6: FDA Approval of Risperidone
  by Autism Speaks
In honor of the anniversary of Autism Speaks’ founding on Feb 25, for the next 25 days we will be sharing stories about the many significant scientific advances […]


A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
  by sjennings29
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently, Bipolar Disorders, Volume 11, Number 8, December […]


5|25: Celebrating Five Years of Autism Science Day 22: Combined Therapies Hold Promise for More Effective Treatments
  by Autism Speaks
In honor of the anniversary of Autism Speaks’ founding on Feb 25, for the next 25 days we will be sharing stories about the many significant scientific advances […]


Risperidone Versus Placebo for Schizophrenia
  by Qrd
Risperidone Versus Placebo for Schizophrenia -- Rattehalli et al. 36 (3): 448 -- Schizophrenia Bulletin. Why am I not surprised? The conclusions: Risperidone appears to have a marginal benefit in […]


Risperdal (Risperidone) Lawsuit
  by Your Friend
Risperdal, which is manufactured by Janssen Pharmaceuticals, a division of Johnson & Johnson, is another member of the family of drugs knows as  Atypical Antipsychotics. Risperdal has been […]



Other reviews about Risperidone on web:

Risperidone (pronounced Ris-PEAR-rǐ-dōne) is an atypical antipsychotic used to treat schizophrenia (including adolescent schizophrenia), schizoaffective disorder, the mixed ... Risperidone - Wikipedia, the free encyclopedia


Risperidone (Risperdal) is used to treat schizophrenia and symptoms of bipolar disorder. Includes risperidone side effects, interactions and indications. Risperidone Information from Drugs.com


Features information about dosage, usage, warnings, and side effects. Risperidone: MedlinePlus Drug Information


risperidone n trade name: Risperdal; drug class: antipsychotic; action: may be related to antagonism for dopamine and serotonin receptors; also has Risperidone: Definition from Answers.com


Information about the drug risperidone (Risperdal) prescribed for mania, schizophrenia, stuttering, Tourette syndrome, and OCD (obsessive compulsive disorder). risperidone (Risperdal) - drug class, medical uses, medication ...


Learn about the prescription medication Risperdal (Risperidone), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Risperdal (Risperidone) Drug Information: Uses, Side Effects, Drug ...


RISPERDAL ® (risperidone) is not approved for the treatment of patients with dementia-related psychosis. The most common adverse reactions observed in all ... Risperdal.com


Comprehensive and trusted information about Risperidone - plus advice on 24,000 other FDA approved drugs and medications from Drugs.com. Risperidone patient advice including side effects


Consumer information about the medication RISPERIDONE - ORAL (Risperdal), includes side effects, drug interactions, recommended dosages, and storage information. Read more ... RISPERIDONE - ORAL (Risperdal) side effects, medical uses, and ...


Risperidone is a medication used to treat bipolar disorder, schizophrenia, and irritability due to autism. This eMedTV resource offers an overview of risperidone, including ... Risperidone





Featured Reviews

Reviews Thrombin-JMI

Thrombin-JMI Drug Description THROMBIN, TOPICAL U.S.P. (bovine origin) THROMBIN-JMI® Thrombin, Topical (Bovine) must not be injected! Apply on the surface of bleeding tissue. DRUG DESCRIPTION The thrombin in Thrombin, Topical...
Read More  |  Review This
Reviews Hydrocortisone Cream and Ointment 1.0%

Cortaid Drug Description DRUG DESCRIPTION What are the possible side effects of hydrocortisone topical? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling...
Read More  |  Review This
Reviews Pediotic

Pediotic Drug Description PEDIOTIC® Suspension Sterile (neomycin and polymyxin B sulfates and hydrocortisone) Otic Suspension, USP DRUG DESCRIPTION PEDIOTIC® Suspension (neomycin and polymyxin B sulfates and hydrocortisone ...
Read More  |  Review This
Reviews Tretinoin

Vesanoid Drug Description VESANOID® (tretinoin) Capsules WARNINGS 1. Experienced Physician and Institution Patients with acute promyelocytic leukemia (APL) are at high risk in general and can have severe adverse reactions to VESANOID...
Read More  |  Review This
Reviews Mecasermin [rDNA origin] Injection

Increlex Drug Description INCRELEX® (mecasermin [rDNA origin]) Injection DRUG DESCRIPTION What are the possible side effects of mecasermin (Increlex)? Get emergency medical help if your child has any of these signs of an allergic...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....